Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyna Turner

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Frontiers in Psychiatry|February 21, 2025
"Holding on to Hope": follow up qualitative findings of a tobacco treatment intervention for people experiencing mental health conditionsTessa-May Zirnsak, Kristen McCarter, Melissa L McKinlay, et al.
The Australian and New Zealand Journal of Psychiatry|October 31, 2019
Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive <i>N</i>-acetylcysteine and mitochondrial agents in adults with bipolar disorder: A sub-study of a randomised placebo-controlled trialMelanie M Ashton, Olivia M Dean, Wolfgang Marx, et al.
Frontiers in Psychiatry|June 20, 2022
Adapting Peer Researcher Facilitated Strategies to Recruit People Receiving Mental Health Services to a Tobacco Treatment TrialAmanda L Baker, Kristen McCarter, Lisa Brophy, et al.
Journal of Affective Disorders|September 11, 2025
Adverse childhood experiences and cardiometabolic risk factors in people with bipolar disorderAlyna Turner, Maya Kuperberg, Hugh McGovern, et al.
The Australian and New Zealand Journal of Psychiatry|June 24, 2023
'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health servicesAmanda L Baker, Kristen McCarter, Alyna Turner, et al.
Trials|June 6, 2019
A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependenceRebecca McKetin, Olivia M Dean, Alyna Turner, et al.
Drug and Alcohol Review|October 6, 2020
Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trialRebecca McKETIN, Brendan Quinn, Peter Higgs, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|October 18, 2018
Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trialMelanie M Ashton, Michael Berk, Chee H Ng, et al.
Acta Psychiatrica Scandinavica|March 4, 2022
Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorderAnna L Wrobel, Ole Köhler-Forsberg, Louisa G Sylvia, et al.
Molecular Psychiatry|June 29, 2023
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidineSourav Khanra, Preethi Reddy, Anna Giménez-Palomo, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Frontiers in Psychiatry|February 21, 2025
"Holding on to Hope": follow up qualitative findings of a tobacco treatment intervention for people experiencing mental health conditionsTessa-May Zirnsak, Kristen McCarter, Melissa L McKinlay, et al.
The Australian and New Zealand Journal of Psychiatry|October 31, 2019
Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive <i>N</i>-acetylcysteine and mitochondrial agents in adults with bipolar disorder: A sub-study of a randomised placebo-controlled trialMelanie M Ashton, Olivia M Dean, Wolfgang Marx, et al.
Frontiers in Psychiatry|June 20, 2022
Adapting Peer Researcher Facilitated Strategies to Recruit People Receiving Mental Health Services to a Tobacco Treatment TrialAmanda L Baker, Kristen McCarter, Lisa Brophy, et al.
Journal of Affective Disorders|September 11, 2025
Adverse childhood experiences and cardiometabolic risk factors in people with bipolar disorderAlyna Turner, Maya Kuperberg, Hugh McGovern, et al.
The Australian and New Zealand Journal of Psychiatry|June 24, 2023
'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health servicesAmanda L Baker, Kristen McCarter, Alyna Turner, et al.
Trials|June 6, 2019
A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependenceRebecca McKetin, Olivia M Dean, Alyna Turner, et al.
Drug and Alcohol Review|October 6, 2020
Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trialRebecca McKETIN, Brendan Quinn, Peter Higgs, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|October 18, 2018
Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trialMelanie M Ashton, Michael Berk, Chee H Ng, et al.
Acta Psychiatrica Scandinavica|March 4, 2022
Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorderAnna L Wrobel, Ole Köhler-Forsberg, Louisa G Sylvia, et al.
Molecular Psychiatry|June 29, 2023
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidineSourav Khanra, Preethi Reddy, Anna Giménez-Palomo, et al.
Pageof 12